GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (CHIX:VIRPp) » Definitions » Loans Receivable

Virbac (CHIX:VIRPP) Loans Receivable : €0 Mil (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Virbac Loans Receivable?

Virbac's Loans Receivable for the quarter that ended in Jun. 2024 was €0 Mil.


Virbac Loans Receivable Historical Data

The historical data trend for Virbac's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Loans Receivable Chart

Virbac Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Virbac Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Virbac Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Virbac Loans Receivable Related Terms

Thank you for viewing the detailed overview of Virbac's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.

Virbac Headlines

No Headlines